Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Controlled Substance Market Valued at Present and by 2029?

In recent years, the controlled substance market has seen a significant expansion. The market size, which is projected to be $94.86 billion in 2024, is expected to increase to $100.19 billion in 2025 with a compound annual growth rate (CAGR) of 5.6%. The surge in growth during the historic period is due to factors such as advancements in medicine, regulatory frameworks, an upswing in chronic diseases, growth in the pharmaceutical industry, international commerce, and cooperation.

Expectations are high for robust expansion in the controlled substance market in the coming years. The projected advancement suggests a growth to $133.97 billion in 2029, with a compound annual growth rate (CAGR) of 7.5%. This anticipated growth can be credited to factors such as precision medicine, telemedicine and remote healthcare, alternatives to opioids, constant regulatory updates, and a heightened focus on mental health. Key trends for the forecasted period involve regulatory modifications and compliance, an intensified emphasis on drug safety and abuse prevention, progress in drug delivery technologies, the introduction of biosimilars and generic drugs, along with the incorporation of digital health solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9898&type=smp

#What Drivers Are Influencing Growth In The Controlled Substance Market?

The growth of the controlled substance market is anticipated to be fueled by the rising demand for medically prescribed drugs. Prescription medication is designed for use in treating, curing, managing, therapeutically intervening, or preventing diseases, and is frequently classified as a controlled substance. The controlled substance market benefits from prescription drugs as they can improve patient outcomes and decrease unnecessary expenditure. In September 2024, the Centers for Medicare and Medicaid Services (CMS), a federal agency in the U.S., reported that spending on prescription drugs rose by 8.4% to $405.9 billion in 2022, marking an increase from the 6.8% growth observed in 2021. As such, the surge in demand for medically prescribed drugs is contributing significantly to the expansion of the controlled substance market.

What Are The Main Segments Identified In The Controlled Substance Market Research?

The controlled substance market covered in this report is segmented –

1) By Drug: Opioids, Stimulant, Depressants, Cannabinoids

2) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

3) By Application: Pain Management, Sleep Disorders, Depression And Anxiety, Seizure, Attention Deficit Hyperactivity Disorder (ADHD), Other Applications

Subsegments:

1) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids

2) By Stimulants: Amphetamines, Methylphenidate, Cocaine

3) By Depressants: Benzodiazepines, Barbiturates, Sleep Medications

4) By Cannabinoids: THC (Tetrahydrocannabinol), CBD (Cannabidiol), Synthetic Cannabinoids

What Are The Leading Trends And Opportunities In The Controlled Substance Sector?

The emergence of product innovations is becoming a significant trend in the controlled substance market. To maintain their market share, major companies in this field are exploring new product and drug developments. An illustration of this occurred in January 2022 when CareFlow Medicines Management Ltd. (CMM), a UK-based medicine management solution provider, collaborated with Modeus, a healthcare software provider in Australia. The partnership resulted in the Controlled Drug Manager (CD Manager), an inventive platform designed to securely manage and track controlled drugs, including those owned by patients. The newly launched CMM CD Manager, which runs on Modeus, can interface with CMM’s medication management platform as well as other external systems. It is designed for use by healthcare staff and pharmacists within the pharmaceutical, ward, and theatre environments of hospitals that store controlled medications. The CD Manager, with its integrated reporting feature, aids Controlled Drug Accountable Officers in monitoring the controlled drugs’ life cycle within their organizations. It allows them to swiftly respond to automated alerts about discrepancies or potential diversions.

Which Companies Play A Key Role In The Development Of The Controlled Substance Market?

Major companies operating in the controlled substance market include Merck & Co. Inc., Johnson and Johnson Services Inc., Orbis Biosciences Inc., GW Pharmaceuticals plc, Corium Inc., Aradigm Corporation, Alkermes plc, Sun Pharmaceutical Ltd., F. Hoffmann-La Roche Ltd., AbbVie Inc., Ampac Fine Chemicals, Siegfried Holding AG, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, Sanofi S.A., Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Teva Pharmaceutical Industries, Viatris Inc., Boehringer Ingelheim, Gilead Sciences, Amgen, Regeneron Pharmaceuticals, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Endo International, Catalent, Cambrex Corporation, Lonza Group, Indivior plc, Ipsen SA

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/controlled-substance-global-market-report

What Are The Key Regional Developments Shaping The Controlled Substance Market?

North America was the largest region in the controlled substance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the controlled substance market report during the forecast period. The regions covered in the controlled substance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9898&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model